Injective INJ
Current Price
$4.58 -3.28%
$0.2600 Daily Range (5.68%)
$4.50$4.76
$45.54M Daily Volume
512 BTC
Vol/MktCap: 9.95%
Market Performance
0.09% Relative BTC Volume
The total volume of Injective is $45.54M over the past 24 hours, compared to $52.32B total Bitcoin volume.
Hourly Moving Average
8 SMA $4.67 -1.87%
13 SMA $4.67 -2.00%
21 SMA $4.67 -1.91%
55 SMA $4.64 -1.29%
144 SMA $4.93 -7.04%
Price Performance
-1.68% 1 Hour Change
$4.58 from $4.66
-13.77% 7 Day Change
-$0.6306 from $5.21
-12.53% 14 Day Change
-$0.5740 from $5.15
+0.79% 30 Day Change
$0.0360 from $4.54
All Time High
March 14, 2024
$52.62 -91.30%
-$48.04 vs. now
24H Change
-15.80M USD -3.34%
-177 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
5.01 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
9.84M INJ
traded over past 24 hours
9.84% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently trading at $4.58, reflecting a 24-hour change of -2.87%. The price has seen a daily range of $0.26, with a high of $4.76 and a low of $4.50, indicating a relatively stable trading environment despite the slight downward trend.
The volume over the last 24 hours stands at approximately 46.13 million, contributing to a volume-to-market cap ratio of 10.07%. Moving averages reveal a bearish sentiment, with the 8, 13, and 21-period SMAs all showing declines, while the 144-period SMA indicates a more significant downturn of -7.04% from its average price, suggesting weakness in the medium to long-term trend.
Short-term momentum indicators reveal an oversold condition, with the 1-hour RSI at 31, indicating potential for a price rebound. However, the 7-day RSI at 45 suggests that the asset is still trading in a neutral zone but has experienced a notable decline of 13.82% over the past week and 9.68% over the past two weeks, reflecting a deteriorating market sentiment.
Despite a slight uptick of 1.40% over the last 30 days, the recent bearish trends and the significant distance from its all-time high of $52.62 indicate a challenging market environment for INJ. Given the current price action, volume trends, and moving averages, there is a risk of further downside in the short term.
Based on this analysis, the recommendation is to Hold. While there are signs of potential overselling, the overall trend remains bearish, and a clearer signal of recovery is needed before considering a Buy.
The volume over the last 24 hours stands at approximately 46.13 million, contributing to a volume-to-market cap ratio of 10.07%. Moving averages reveal a bearish sentiment, with the 8, 13, and 21-period SMAs all showing declines, while the 144-period SMA indicates a more significant downturn of -7.04% from its average price, suggesting weakness in the medium to long-term trend.
Short-term momentum indicators reveal an oversold condition, with the 1-hour RSI at 31, indicating potential for a price rebound. However, the 7-day RSI at 45 suggests that the asset is still trading in a neutral zone but has experienced a notable decline of 13.82% over the past week and 9.68% over the past two weeks, reflecting a deteriorating market sentiment.
Despite a slight uptick of 1.40% over the last 30 days, the recent bearish trends and the significant distance from its all-time high of $52.62 indicate a challenging market environment for INJ. Given the current price action, volume trends, and moving averages, there is a risk of further downside in the short term.
Based on this analysis, the recommendation is to Hold. While there are signs of potential overselling, the overall trend remains bearish, and a clearer signal of recovery is needed before considering a Buy.
Updated 15 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
You May Also Like
In The News

Bitgo Becomes First Crypto Firm to Go Public in 2026
Bitgo has priced its initial public offering (IPO) at $18 per share, raising about $213 million and entering public markets with a valuation of roughly $2 billion.

Perp DEXs Are Growing Fast, but Do They Really Threaten CEXs? MEXC COO Explains
Perpetual decentralized exchanges (perp DEXs) gained strong traction in 2025.

UK government borrowing fell to £11.6 billion in December, below £13 billion forecast
UK government borrowing fell to £11.6 billion in December, below economists’ £13 billion forecast.

MYX rallies 12% – Can bulls control $6.12 resistance?
MYX rallies 12%, boosted by the V2 airdrop.